Kyle Rose
Stock Analyst at Canaccord Genuity
(4.33)
# 416
Out of 4,667 analysts
114
Total ratings
54.44%
Success rate
15.66%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FNA Paragon 28 | Maintains: Buy | $17 → $15 | $10.35 | +44.93% | 3 | Nov 13, 2024 | |
| SYK Stryker | Maintains: Buy | $360 → $400 | $385.68 | +3.71% | 19 | Oct 30, 2024 | |
| PODD Insulet | Maintains: Buy | $226 → $234 | $266.58 | -12.22% | 15 | May 10, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $83.59 | -15.06% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $44.78 | +58.55% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $18.24 | +20.61% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.49 | +571.14% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $9.93 | +121.55% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $75.24 | +99.36% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $9.03 | +2,890.03% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $12.15 | +122.22% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.90 | +417.24% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $12.90 | +16.28% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $155.77 | -21.68% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.65 | +9.59% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.41 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $109.27 | +14.40% | 7 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $55 | $25.21 | +118.17% | 5 | Apr 30, 2021 |
Paragon 28
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $10.35
Upside: +44.93%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $385.68
Upside: +3.71%
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $266.58
Upside: -12.22%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $83.59
Upside: -15.06%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $44.78
Upside: +58.55%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $18.24
Upside: +20.61%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $9.93
Upside: +121.55%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $75.24
Upside: +99.36%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $9.03
Upside: +2,890.03%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $12.15
Upside: +122.22%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $2.90
Upside: +417.24%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $12.90
Upside: +16.28%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $155.77
Upside: -21.68%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.65
Upside: +9.59%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $11.41
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $109.27
Upside: +14.40%
Apr 30, 2021
Maintains: Buy
Price Target: $53 → $55
Current: $25.21
Upside: +118.17%